- Drug Pipelines
- January 2022
- 30 Pages
Global
From €482EUR$500USD£412GBP
- Report
- January 2019
- 35 Pages
Global
From €964EUR$1,000USD£825GBP
The Zactos market is a segment of the Endocrine and Metabolic Disorders Drugs market. It includes drugs used to treat conditions such as diabetes, obesity, and thyroid disorders. These drugs are used to regulate hormones and metabolism, and can be administered orally, intravenously, or through injections. Zactos drugs are typically prescribed to patients with chronic conditions, and are often used in combination with lifestyle changes and other medications.
The Zactos market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. Other companies such as Boehringer Ingelheim, Takeda, and Pfizer also offer products in this market. Show Less Read more